2004
DOI: 10.1016/j.canlet.2004.05.012
|View full text |Cite
|
Sign up to set email alerts
|

Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apcmin mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
14
2
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 18 publications
3
14
2
1
Order By: Relevance
“…1, PEG significantly decreased tumorigenesis by 76% (P < 0.001), total ACF by 74% (P < 0.001), and complex ACF by 64% (P < 0.001; n = 12 from each group). These results are in agreement with numerous other reports showing remarkable efficacy of PEG in suppressing ACF and tumor development (17,35).…”
Section: Peg Inhibits Initiation Of Colon Carcinogenesis In Azoxymethsupporting
confidence: 93%
See 2 more Smart Citations
“…1, PEG significantly decreased tumorigenesis by 76% (P < 0.001), total ACF by 74% (P < 0.001), and complex ACF by 64% (P < 0.001; n = 12 from each group). These results are in agreement with numerous other reports showing remarkable efficacy of PEG in suppressing ACF and tumor development (17,35).…”
Section: Peg Inhibits Initiation Of Colon Carcinogenesis In Azoxymethsupporting
confidence: 93%
“…Our results from the cell culture, in keeping with the study from Corpet's laboratory (26), indicate that PEG has a marked cytoprotective effect. Furthermore, antiproliferative effect of PEG complements its proapoptotic effect that we have previously reported in cell culture, azoxymethane-treated rat, and the MIN mouse (17,41).…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…To keep these results in perspective, PEG outperformed all other chemopreventive agents including well established agents such as NSAIDs. Our group confirmed that this was not model-specific by demonstrating the efficacy of PEG 3350 in the MIN (multiple intestinal neoplasias) mouse model, a genetically driven model of intestinal neoplasia (23). While definitive (randomized placebo-controlled) studies are ongoing, it is heartening to note a 52% neoplasia risk reduction with PEG in a casecontrol study (15).…”
Section: Discussionmentioning
confidence: 59%
“…O medicamento polietilenoglicol tem a capacidade de reprimir EGFR, funcionando como um quimiopreventivo eficaz contra o câncer colorretal (158)(159)(160) .…”
Section: Ciclina D1unclassified